Literature DB >> 32520539

Correction to Efficient Targeted Degradation via Reversible and Irreversible Covalent PROTACs.

Ronen Gabizon, Amit Shraga, Paul Gehrtz, Ella Livnah, Yamit Shorer, Neta Gurwicz, Liat Avram, Tamar Unger, Hila Aharoni, Shira Albeck, Alexander Brandis, Ziv Shulman, Ben-Zion Katz, Yair Herishanu, Nir London.   

Abstract

Year:  2020        PMID: 32520539     DOI: 10.1021/jacs.0c05753

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


× No keyword cloud information.
  4 in total

Review 1.  Proteolysis-targeting chimaeras (PROTACs) as pharmacological tools and therapeutic agents: advances and future challenges.

Authors:  Chao Wang; Yujing Zhang; Tingting Zhang; Lingyu Shi; Zhongmin Geng; Dongming Xing
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

2.  Development of NanoLuc-targeting protein degraders and a universal reporter system to benchmark tag-targeted degradation platforms.

Authors:  Christoph Grohmann; Charlene M Magtoto; Joel R Walker; Ngee Kiat Chua; Anna Gabrielyan; Mary Hall; Simon A Cobbold; Stephen Mieruszynski; Martin Brzozowski; Daniel S Simpson; Hao Dong; Bridget Dorizzi; Annette V Jacobsen; Emma Morrish; Natasha Silke; James M Murphy; Joan K Heath; Andrea Testa; Chiara Maniaci; Alessio Ciulli; Guillaume Lessene; John Silke; Rebecca Feltham
Journal:  Nat Commun       Date:  2022-04-19       Impact factor: 14.919

3.  Reversible Covalent PROTACs: Novel and Efficient Targeted Degradation Strategy.

Authors:  Minghua Yuan; Yanan Chu; Yongtao Duan
Journal:  Front Chem       Date:  2021-07-05       Impact factor: 5.221

4.  Bardoxolone conjugation enables targeted protein degradation of BRD4.

Authors:  Bingqi Tong; Mai Luo; Yi Xie; Jessica N Spradlin; John A Tallarico; Jeffrey M McKenna; Markus Schirle; Thomas J Maimone; Daniel K Nomura
Journal:  Sci Rep       Date:  2020-09-23       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.